• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and How.

作者信息

Pal Sumanta K, Swami Umang, Agarwal Neeraj

机构信息

Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

出版信息

Eur Urol. 2020 Jan;77(1):22-23. doi: 10.1016/j.eururo.2019.06.029. Epub 2019 Jul 9.

DOI:10.1016/j.eururo.2019.06.029
PMID:31300236
Abstract
摘要

相似文献

1
Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and How.解析晚期前列腺癌中的Wnt信号通路：时机、原因及方式
Eur Urol. 2020 Jan;77(1):22-23. doi: 10.1016/j.eururo.2019.06.029. Epub 2019 Jul 9.
2
Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer.Wnt信号通路激活突变与去势抵抗性前列腺癌对一线阿比特龙和恩杂鲁胺的耐药性相关。
Eur Urol. 2020 Jan;77(1):14-21. doi: 10.1016/j.eururo.2019.05.032. Epub 2019 Jun 5.
3
Re: Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer.回复：Wnt信号通路激活突变与去势抵抗性前列腺癌对一线阿比特龙和恩杂鲁胺的耐药性相关。
Eur Urol. 2020 Mar;77(3):393. doi: 10.1016/j.eururo.2019.10.014. Epub 2019 Nov 12.
4
Therapeutic Discovery for Castration Resistant Prostate Cancer: Patient-derived Xenograft Modelling Brings New Options to the Table.
Eur Urol. 2018 Nov;74(5):573-574. doi: 10.1016/j.eururo.2018.06.049. Epub 2018 Jul 13.
5
Current understanding of resistance to abiraterone  and enzalutamide in advanced prostate cancer.晚期前列腺癌中对阿比特龙和恩杂鲁胺耐药的当前认识。
Clin Adv Hematol Oncol. 2016 May;14(5):316-9.
6
Prostate cancer: AR aberrations and resistance to abiraterone or enzalutamide.前列腺癌：雄激素受体异常与对阿比特龙或恩杂鲁胺的耐药性。
Nat Rev Urol. 2016 Dec;13(12):697-698. doi: 10.1038/nrurol.2016.212. Epub 2016 Nov 2.
7
Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration-resistant prostate cancer.抑制非经典 Wnt 通路可克服去势抵抗性前列腺癌对恩杂鲁胺的耐药性。
Prostate. 2020 Feb;80(3):256-266. doi: 10.1002/pros.23939. Epub 2019 Dec 19.
8
Chemotherapy, not androgen receptor-targeted therapy should be used upfront for metastatic hormone-sensitive prostate cancer. CON: Novel oral agents provide an attractive alternative to chemotherapy in metastatic hormone-sensitive prostate cancer.对于转移性激素敏感性前列腺癌，应首先使用化疗而非雄激素受体靶向治疗。反对意见：新型口服药物为转移性激素敏感性前列腺癌的化疗提供了一种有吸引力的替代方案。
Curr Opin Urol. 2020 Jul;30(4):620-622. doi: 10.1097/MOU.0000000000000694.
9
Re: Germline DNA-Repair Gene Mutations and Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Receiving First-Line Abiraterone and Enzalutamide.
J Urol. 2018 Nov;200(5):945. doi: 10.1016/j.juro.2018.08.026. Epub 2018 Aug 16.
10
Towards random sequencing or precision medicine in castration-resistant prostate cancer?去势抵抗性前列腺癌是走向随机测序还是精准医学？
Eur Urol. 2014 Jan;65(1):37-8. doi: 10.1016/j.eururo.2013.09.019. Epub 2013 Sep 19.

引用本文的文献

1
Stemness regulation in prostate cancer: prostate cancer stem cells and targeted therapy.前列腺癌中的干性调控：前列腺癌干细胞与靶向治疗
Ann Med. 2025 Dec;57(1):2442067. doi: 10.1080/07853890.2024.2442067. Epub 2024 Dec 23.
2
TCF7L1 regulates cytokine response and neuroendocrine differentiation of prostate cancer.TCF7L1调节前列腺癌的细胞因子反应和神经内分泌分化。
Oncogenesis. 2021 Nov 20;10(11):81. doi: 10.1038/s41389-021-00371-6.
3
Targeting cancer stem cell pathways for cancer therapy.针对癌症干细胞通路的癌症治疗。
Signal Transduct Target Ther. 2020 Feb 7;5(1):8. doi: 10.1038/s41392-020-0110-5.
4
Wnt-C59 Attenuates Pressure Overload-Induced Cardiac Hypertrophy via Interruption of Wnt Pathway.Wnt-C59 通过阻断 Wnt 通路减轻压力超负荷诱导的心肌肥厚。
Med Sci Monit. 2020 Apr 12;26:e923025. doi: 10.12659/MSM.923025.